HealthScienceTechnologyWorld

Global Orphan Drugs Market || keyplayers Amgen Merck & Co. Inc. Jazz Pharmaceuticals

Introduction:

Orphan drugs are the pharmaceutical mediators which are developed to treat rare medical conditions. Orphan drugs would not be able to earn profit because the orphan drugs are used to treat the rare diseases. It can only produce profit by the involvement of government assistant. Orphan drugs use to diagnoses and to prevent the diseases. Orphan drugs are not developed in industry, but it is generated for the public welfare.

Drivers and Restraints:

Orphan drugs market is extensively high for orphan drug developers which is the major propelling factor for the growth of target market. In addition, the orphan drugs can treat the diseases type such as cardiology, oncology, and hematology, neurology which is the boosting factor for the growth of global market. As per the data published by WHO (World’s Health Organization), globally in 2016, cardiovascular diseases (CVD) are the main cause of death, around 17.9 million people died due to CVDs, which represented 31% of all deaths, globally. Additionally, Increases prevalence in the rare diseases is another fuelling factor for the growth of global market. Moreover, favorable government policies on the use of orphan drugs which is further propelling factor for the growth of the target market. However, high cost of pre patient restrain the growth of the global market. Furthermore, limited patient pool for the product marketing and clinical trials hampers growth of the target market. Nevertheless, increase in the government or FDA approval for the orphan drugs can create an opportunity for the growth of global orphan drugs market.

Request free sample:-https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3793
  1. Global Orphan Drugs Market, By Drug Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Biological
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non- Biological
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  2. Global Orphan Drugs Market, By Top Selling Drugs, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Revlimid
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Rituxan
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Copaxone
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Opdivo
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Keytruda
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Imbruvica
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Avonex
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sensipar
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Soliris
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Top Selling Drugs
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  3. Global Orphan Drugs Market, By Disease Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Oncology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurology
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cardiovascular
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Disease Type
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  4. Global Orphan Drugs Market, By Phase, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Phase I
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase II
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase III
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Phase IV
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 –2030
    • Company Profile:
      • AbbVie Inc.*
            • Company Overview
            • Drug Type Portfolio
            • Key Highlights
            • Financial Performance
      • Celgene Corporation
      • Biogen
      • Teva Pharmaceutical Industries
      • F. Hoffmann-La Roche AG
      • Bristol-Myers Squibb Company
      • Alexion Pharmaceuticals
      • Amgen
      • Merck & Co. Inc.
      • Jazz Pharmaceuticals
    • Contact Us:

      Mr. Alex (Sales Manager)

      Prophecy Market Insights

      Phone: +1 860 531 2701

      +91 777 504 9802
      Email: sales@prophecymarketinsights.com

Back to top button